Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Keisuke Ueda

Showing results (21-30 of 166) with videos related to

Pageof 17
Sort By:
Pediatrics|April 4, 2018
Clinical Benefit of NMDA Receptor Antagonists in a Patient With <i>ATP1A2</i> Gene MutationKeisuke Ueda, Fatema Serajee, Ahm M Huq
Neurology. Genetics|May 14, 2021
Paroxysmal Kinesigenic Dyskinesia in Twins With Chromosome 16p11.2 Duplication SyndromeKeisuke Ueda, Marwan Shinawi, Toni S Pearson
Molecular Pharmaceutics|November 29, 2021
Transition from Amorphous Cyclosporin A Nanoparticles to Size-Reduced Stable Nanocrystals in a Poloxamer 407 SolutionZiqiao Chen, Kenjirou Higashi, Keisuke Ueda, et al.
International Journal of Pharmaceutics|April 29, 2017
Effect of guest drug character encapsulated in the cavity and intermolecular spaces of γ-cyclodextrins on the dissolution property of ternary γ-cyclodextrin complexNan Liu, Kenjirou Higashi, Keisuke Ueda, et al.
Molecular Pharmaceutics|September 13, 2013
Inhibitory effect of hydroxypropyl methylcellulose acetate succinate on drug recrystallization from a supersaturated solution assessed using nuclear magnetic resonance measurementsKeisuke Ueda, Kenjirou Higashi, Keiji Yamamoto, et al.
Journal of Pharmaceutical Sciences|September 2, 2024
Amorphous solubility advantage: Theoretical considerations, experimental methods, and contemporary relevanceKeisuke Ueda, Dana E Moseson, Lynne S Taylor
International Journal of Pharmaceutics|August 14, 2021
Revealing the mechanism of morphological variation of amorphous drug nanoparticles formed by aqueous dispersion of ternary solid dispersionZhijing Zhao, Kenjirou Higashi, Keisuke Ueda, et al.
Molecular Pharmaceutics|February 28, 2015
Equilibrium state at supersaturated drug concentration achieved by hydroxypropyl methylcellulose acetate succinate: molecular characterization using (1)H NMR techniqueKeisuke Ueda, Kenjirou Higashi, Keiji Yamamoto, et al.
International Journal of Pharmaceutics|March 24, 2023
Supersaturation maintenance of carvedilol and chlorthalidone by cyclodextrin derivatives: Pronounced crystallization inhibition ability of methylated cyclodextrinMengyao Liu, Kenjirou Higashi, Keisuke Ueda, et al.
Journal of Pharmaceutical Sciences|November 3, 2025
Role of carriers and pre-dissolved polymers in drug-rich nanodroplet formation during dissolution of amorphous drug formulationsRei Hakata, Keisuke Ueda, Kenjirou Higashi, et al.
Pageof 17

Showing results (21-30 of 166) with videos related to

Sort By:
Pageof 17
Pediatrics|April 4, 2018
Clinical Benefit of NMDA Receptor Antagonists in a Patient With <i>ATP1A2</i> Gene MutationKeisuke Ueda, Fatema Serajee, Ahm M Huq
Neurology. Genetics|May 14, 2021
Paroxysmal Kinesigenic Dyskinesia in Twins With Chromosome 16p11.2 Duplication SyndromeKeisuke Ueda, Marwan Shinawi, Toni S Pearson
Molecular Pharmaceutics|November 29, 2021
Transition from Amorphous Cyclosporin A Nanoparticles to Size-Reduced Stable Nanocrystals in a Poloxamer 407 SolutionZiqiao Chen, Kenjirou Higashi, Keisuke Ueda, et al.
International Journal of Pharmaceutics|April 29, 2017
Effect of guest drug character encapsulated in the cavity and intermolecular spaces of γ-cyclodextrins on the dissolution property of ternary γ-cyclodextrin complexNan Liu, Kenjirou Higashi, Keisuke Ueda, et al.
Molecular Pharmaceutics|September 13, 2013
Inhibitory effect of hydroxypropyl methylcellulose acetate succinate on drug recrystallization from a supersaturated solution assessed using nuclear magnetic resonance measurementsKeisuke Ueda, Kenjirou Higashi, Keiji Yamamoto, et al.
Journal of Pharmaceutical Sciences|September 2, 2024
Amorphous solubility advantage: Theoretical considerations, experimental methods, and contemporary relevanceKeisuke Ueda, Dana E Moseson, Lynne S Taylor
International Journal of Pharmaceutics|August 14, 2021
Revealing the mechanism of morphological variation of amorphous drug nanoparticles formed by aqueous dispersion of ternary solid dispersionZhijing Zhao, Kenjirou Higashi, Keisuke Ueda, et al.
Molecular Pharmaceutics|February 28, 2015
Equilibrium state at supersaturated drug concentration achieved by hydroxypropyl methylcellulose acetate succinate: molecular characterization using (1)H NMR techniqueKeisuke Ueda, Kenjirou Higashi, Keiji Yamamoto, et al.
International Journal of Pharmaceutics|March 24, 2023
Supersaturation maintenance of carvedilol and chlorthalidone by cyclodextrin derivatives: Pronounced crystallization inhibition ability of methylated cyclodextrinMengyao Liu, Kenjirou Higashi, Keisuke Ueda, et al.
Journal of Pharmaceutical Sciences|November 3, 2025
Role of carriers and pre-dissolved polymers in drug-rich nanodroplet formation during dissolution of amorphous drug formulationsRei Hakata, Keisuke Ueda, Kenjirou Higashi, et al.
Pageof 17